Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.
Druker
B J
BJ
Oregon Health & Science University, USA.
D000970:Antineoplastic Agents / Q000266:history / Q000627:therapeutic use* / Q000633:toxicity; D001549:Benzamides; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010879:Piperazines / Q000266:history / Q000627:therapeutic use* / Q000633:toxicity; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000266:history / Q000627:therapeutic use* / Q000633:toxicity
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases